RF Ablation vs Cryoablation for AFib: Key Differences

Research-informed explainer — last updated 2026-04-11

If you have been diagnosed with atrial fibrillation (AFib) and told that catheter ablation is an option, you will likely hear the terms radiofrequency ablation and cryoablation. Both procedures target the same electrical triggers in your heart using different forms of energy to create scar tissue. For paroxysmal AFib, the two techniques produce similar success rates, and a newer approach called pulsed field ablation is now showing comparable results with a more favorable safety profile. The choice between them is largely made by your electrophysiologist based on your AFib pattern, anatomy, and what the center uses most.

This article draws on peer-reviewed research from electrophysiologists in the Convene directory. Their published work includes landmark clinical trials and major international consensus documents that define how catheter ablation is practiced today, including studies from Douglas Packer at Mayo Clinic, Edward Gerstenfeld at UCSF, and Hugh Calkins at Johns Hopkins Hospital.

What all three procedures have in common

Catheter ablation for AFib targets electrical signals that fire abnormally in the pulmonary veins, the four blood vessels that carry oxygenated blood from the lungs into the left atrium. When those signals misfire, they trigger the chaotic electrical activity that causes AFib. The goal of every ablation technique is pulmonary vein isolation (PVI): electrically disconnecting the pulmonary veins from the rest of the heart by creating a ring of scar tissue around each vein opening.

A worldwide survey of catheter ablation for human AFib with more than 2,800 citations found that ablation is effective in approximately 80% of patients after an average of 1.3 procedures, with roughly 70% of patients not requiring antiarrhythmic drugs during intermediate follow-up [7]. Ablation is also associated with improvements in mortality and stroke outcomes compared to antiarrhythmic drug therapy in eligible patients [1].

A 2012 expert consensus statement that defined the standard framework for when ablation is appropriate and how outcomes should be defined, co-authored by Hugh Calkins at Johns Hopkins, remains one of the most-cited documents in the field with more than 2,700 references [8]. The 2017 consensus expanded indications to include ablation as first-line therapy for selected patients rather than only after antiarrhythmic drugs have failed [4].

Radiofrequency ablation: the flexible workhorse

Radiofrequency (RF) ablation uses electrical energy in the radiofrequency range to heat the tissue at the catheter tip. The heat destroys a small area of heart muscle, creating the scar tissue that blocks the abnormal signals. The catheter is flexible and maneuverable, meaning the electrophysiologist can trace custom lesion patterns anywhere in the heart, not just around the pulmonary veins.

That flexibility is RF ablation's main advantage. For patients with persistent AFib, where additional triggers exist outside the pulmonary veins, or for complex anatomies that do not fit a standard balloon shape, RF allows the operator to go where the problem is.

The technique requires skill. The SMART-AF trial, which tested a contact-force-sensing RF catheter, found that the percentage of time the catheter spent within the operator-targeted contact force range correlated directly with freedom from arrhythmia recurrence at 12 months [3]. Contact force — how firmly the catheter tip presses against the heart wall — determines whether the lesion is deep enough to be permanent. Too little contact and the tissue heals; too much and there is a risk of perforation. Contact-force sensing technology gave electrophysiologists real-time feedback that made this critical variable measurable rather than estimated. The trial confirmed that more consistent contact equals better outcomes. This is a technical skill that experienced RF operators develop over many procedures.

RF ablation is generally preferred for: persistent or long-standing persistent AFib, patients with non-pulmonary vein triggers, and anatomy that does not suit a balloon catheter.

Cryoablation: the standardized balloon approach

Cryoablation uses a balloon catheter filled with extremely cold nitrous oxide gas. When the balloon is positioned at the opening of a pulmonary vein, the gas expands and freezes the surrounding tissue to temperatures below -40°C, creating the ablation lesion. The circular shape of the balloon is specifically designed to conform to the round pulmonary vein ostium.

The main advantage of cryoablation is standardization. Because the balloon is built to fit the pulmonary vein, the procedure is more reproducible across operators than point-by-point RF mapping. Training curves are shorter, and procedure times for paroxysmal AFib are typically faster.

A major clinical trial of cryoballoon ablation for paroxysmal AFib published in the Journal of the American College of Cardiology, with nearly 900 citations, demonstrated the efficacy and safety of the technique and established cryoballoon PVI as a validated first-line ablation strategy for paroxysmal AFib [2]. The trial also identified the key limitation: the balloon ablates the pulmonary vein ostia but cannot create custom lesion shapes elsewhere. If your AFib also involves triggers outside the pulmonary veins, the cryoballoon cannot address them without switching to a point-by-point catheter.

A specific risk with cryoablation is phrenic nerve palsy. The right phrenic nerve runs close to the right superior pulmonary vein, and freezing can temporarily affect diaphragm function. This is usually transient — the nerve recovers in most patients — but it must be monitored during the procedure. Electrophysiologists routinely stimulate the nerve during cryoablation and stop the freeze if diaphragm movement weakens.

Cryoablation is generally preferred for: paroxysmal AFib with standard pulmonary vein anatomy, centers aiming to reduce operator variability, and patients where faster procedure time is a priority.

Pulsed field ablation: the emerging standard

Pulsed field ablation (PFA) is the newest approach. Instead of heat or cold, it uses rapid, high-voltage electrical pulses to cause irreversible electroporation — essentially punching permanent holes in cell membranes. The key advantage is selectivity. Heart muscle cells are more sensitive to electroporation than surrounding tissues like the esophagus and phrenic nerve, which are the structures most at risk from thermal ablation techniques.

The ADVENT trial, published in the New England Journal of Medicine in 2023, was the pivotal study establishing PFA for paroxysmal AFib [5]. The trial compared PFA to conventional thermal ablation — defined as either RF or cryoablation at the operator's discretion — and found that PFA was noninferior with respect to freedom from procedural failure, documented atrial tachyarrhythmia after a three-month blanking period, antiarrhythmic drug use, cardioversion, or repeat ablation at one year. Safety outcomes, including serious adverse events, were also comparable. The result confirmed PFA as a legitimate alternative to both established techniques.

The 2024 international expert consensus statement on catheter and surgical ablation of AFib, co-authored by Gerstenfeld and published in EP Europace, explicitly incorporated PFA as an endorsed treatment approach — a significant step for a technology that was not commercially available in the United States until 2024 [6].

Real-world experience with PFA has generally reported faster procedure times than point-by-point RF mapping and lower rates of esophageal and phrenic nerve complications, though long-term durability data beyond one to two years is still accumulating.

At a glance

What determines which technique your electrophysiologist recommends

For most patients with paroxysmal AFib and standard anatomy, the choice between RF, cryo, and PFA comes down to your electrophysiologist's training and what the center uses most. Outcomes across all three techniques are similar for uncomplicated paroxysmal AFib. Chasing a specific technique is less important than finding an experienced operator.

For patients with persistent or long-standing persistent AFib, RF remains the most flexible option because complex lesion sets beyond pulmonary vein isolation are sometimes needed. The evidence base for cryoballoon and PFA in persistent AFib is less developed, though both are being studied.

Anatomy matters. Patients with unusually shaped pulmonary veins — common veins, very early branching, or atypical ostial sizes — may not be good candidates for the balloon approaches that assume a roughly circular opening. Your electrophysiologist will review a pre-procedure cardiac CT or MRI to assess this.

Prior ablation also matters. For a repeat procedure, RF or PFA may be preferred because the electrophysiologist needs to identify and re-isolate specific gaps in the prior lesion set, which requires precise mapping rather than a standardized balloon application.

Questions to ask your electrophysiologist

• Do I have paroxysmal or persistent AFib, and does that affect which technique you recommend?
• How many ablations have you performed with each technique, and what is your center's success rate?
• What does my cardiac CT show about my pulmonary vein anatomy — is a balloon approach a good fit?
• Is pulsed field ablation available at your center, and would I be a candidate?
• What is the expected success rate for my specific pattern of AFib, and what would a repeat procedure involve if the first one does not work?
• How long is the blanking period after ablation, and what symptoms should prompt me to call before my follow-up?

The bottom line

Radiofrequency ablation, cryoablation, and pulsed field ablation all achieve pulmonary vein isolation through different mechanisms, and all three are supported by strong clinical evidence. For paroxysmal AFib, outcomes are broadly comparable. RF offers the most flexibility for complex cases. Cryoablation offers standardization and is well-validated for paroxysmal AFib. PFA is the newest entrant and the most tissue-selective, with strong one-year data and a rapidly growing evidence base.

What matters most is the experience of the electrophysiologist performing the procedure. A highly skilled operator using any of these three techniques will consistently outperform a less experienced operator using any of the others. When choosing where to have an ablation, ask how many procedures your electrophysiologist has performed, not just which energy source they use.